- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
SILO
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Siloam International Hospitals Tbk · Healthcare · Medical Care Facilities
Latest close
2,380 IDR
8.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -3.9% below the Trend Line and sits at 52.4% of its 52-week range. The latest completed week returned 8.2%, after a 10.2% four-week move. The latest news-sentiment score is 50/100.
Setup score
55
out of 100
Latest Close
2,380 IDR
7 Aug 2026
1W Return
8.2%
latest completed week
4W Return
10.2%
short-term follow-through
12W Return
3.5%
quarterly tape
Trend Breadth
42.3%
22 of 52 weeks active
Volume Ratio
2.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
8.2%
Latest completed week; four-week move 10.2%.
Indicator stack
23/46
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.04%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.9% below the Trend Line and sits at 52.4% of its 52-week range. The latest completed week returned 8.2%, after a 10.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.18
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 10.2% over four weeks, 3.5% over 12 weeks, and 12.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year22
Trend breadth42.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.50Latest activity-pressure read.
Pressure change67.9%Four-week change in activity pressure.
Leadership15.77Latest relative-leadership reading.
RS change1.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.4%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2616 weeks finished lower.
Best week+8.2%Week of 7 Aug.
Worst week-6.9%Week of 19 Jun.
Latest week+8.2%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains6
Flat weeks1
Modest losses10
Sharp losses6
Recent vol4.9%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split21/27Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank8 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Medical Care Facilities
4-week rank4 / 15
Group average3.4%
Trend breadth6.7%
Trend6.7%active weekly trend signals
MD46.7%positive activity pressure
RS73.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 12/12.
Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 42.04%Next-week expectancy is negative with a 42.04% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2,380 IDR | 8.2% | 2,475 IDR | 2,463 IDR | -0.50 | 15.77 | 4.0M | Off |
| 31 Jul 2026 | 2,200 IDR | 7.8% | 2,479 IDR | 2,461 IDR | -1.02 | 10.59 | 1.4M | Off |
| 24 Jul 2026 | 2,040 IDR | -6.4% | 2,493 IDR | 2,459 IDR | -1.26 | 3.69 | 3.2M | Off |
| 17 Jul 2026 | 2,180 IDR | 0.9% | 2,509 IDR | 2,458 IDR | -1.47 | 11.50 | 925.3K | Off |
| 10 Jul 2026 | 2,160 IDR | -2.3% | 2,521 IDR | 2,455 IDR | -1.56 | 15.54 | 780.8K | Off |
| 3 Jul 2026 | 2,210 IDR | 4.7% | 2,532 IDR | 2,453 IDR | -1.55 | 19.56 | 120.3K | Off |
| 26 Jun 2026 | 2,110 IDR | -2.8% | 2,544 IDR | 2,451 IDR | -1.57 | 14.14 | 654.0K | Off |
| 19 Jun 2026 | 2,170 IDR | -6.9% | 2,555 IDR | 2,450 IDR | -1.52 | 12.32 | 673.8K | Off |
| 12 Jun 2026 | 2,330 IDR | 3.1% | 2,566 IDR | 2,449 IDR | -1.45 | 24.33 | 62.3K | Off |
| 5 Jun 2026 | 2,260 IDR | -4.2% | 2,572 IDR | 2,445 IDR | -1.44 | 30.21 | 374.0K | Off |
| 29 May 2026 | 2,360 IDR | -1.3% | 2,575 IDR | 2,440 IDR | -1.37 | 24.84 | 1.3M | Off |
| 22 May 2026 | 2,390 IDR | 3.9% | 2,568 IDR | 2,434 IDR | -1.34 | 26.13 | 2.1M | Off |
| 15 May 2026 | 2,300 IDR | -3.8% | 2,551 IDR | 2,429 IDR | -1.34 | 11.76 | 2.3M | Off |
| 8 May 2026 | 2,390 IDR | -4.4% | 2,536 IDR | 2,425 IDR | -1.18 | 12.12 | 2.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.